Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for HOXA6
Z-value: 1.91
Motif logo
Transcription factors associated with HOXA6
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HOXA6
|
ENSG00000106006.6 | homeobox A6 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HOXA6 | hg19_v2_chr7_-_27187393_27187393 | 0.15 | 4.2e-01 | Click! |
Activity profile of HOXA6 motif
Sorted Z-values of HOXA6 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_-_9933500 | 13.25 |
ENST00000492169.1
|
OFCC1
|
orofacial cleft 1 candidate 1 |
| chr6_+_50061315 | 8.50 |
ENST00000415106.1
|
RP11-397G17.1
|
RP11-397G17.1 |
| chr5_-_76935513 | 8.26 |
ENST00000306422.3
|
OTP
|
orthopedia homeobox |
| chr7_-_27142290 | 6.47 |
ENST00000222718.5
|
HOXA2
|
homeobox A2 |
| chr4_-_41884620 | 6.36 |
ENST00000504870.1
|
LINC00682
|
long intergenic non-protein coding RNA 682 |
| chr2_-_145188137 | 6.32 |
ENST00000440875.1
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
| chr14_-_95236551 | 6.09 |
ENST00000238558.3
|
GSC
|
goosecoid homeobox |
| chr18_-_30353025 | 5.49 |
ENST00000359358.4
|
KLHL14
|
kelch-like family member 14 |
| chr7_-_27205136 | 5.03 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
| chr17_-_39093672 | 4.79 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
| chr2_-_104496621 | 4.64 |
ENST00000455716.1
|
AC013727.1
|
AC013727.1 |
| chr15_-_70390213 | 4.61 |
ENST00000557997.1
ENST00000317509.8 ENST00000442299.2 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr17_-_46262541 | 4.48 |
ENST00000579336.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
| chr1_+_167298281 | 4.19 |
ENST00000367862.5
|
POU2F1
|
POU class 2 homeobox 1 |
| chr6_+_21593972 | 3.87 |
ENST00000244745.1
ENST00000543472.1 |
SOX4
|
SRY (sex determining region Y)-box 4 |
| chr17_-_46671323 | 3.84 |
ENST00000239151.5
|
HOXB5
|
homeobox B5 |
| chr3_-_71353892 | 3.82 |
ENST00000484350.1
|
FOXP1
|
forkhead box P1 |
| chr10_-_10504285 | 3.82 |
ENST00000602311.1
|
RP11-271F18.4
|
RP11-271F18.4 |
| chr3_+_41236325 | 3.80 |
ENST00000426215.1
ENST00000405570.1 |
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa |
| chr12_-_122240792 | 3.78 |
ENST00000545885.1
ENST00000542933.1 ENST00000428029.2 ENST00000541694.1 ENST00000536662.1 ENST00000535643.1 ENST00000541657.1 |
AC084018.1
RHOF
|
AC084018.1 ras homolog family member F (in filopodia) |
| chr15_+_58430368 | 3.70 |
ENST00000558772.1
ENST00000219919.4 |
AQP9
|
aquaporin 9 |
| chr16_-_55478666 | 3.68 |
ENST00000565307.1
|
RP11-212I21.2
|
RP11-212I21.2 |
| chr6_+_50681541 | 3.56 |
ENST00000008391.3
|
TFAP2D
|
transcription factor AP-2 delta (activating enhancer binding protein 2 delta) |
| chr7_-_27183263 | 3.51 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
| chr4_+_74269956 | 3.43 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
| chr12_-_24103954 | 3.43 |
ENST00000441133.2
ENST00000545921.1 |
SOX5
|
SRY (sex determining region Y)-box 5 |
| chr2_+_171571827 | 3.42 |
ENST00000375281.3
|
SP5
|
Sp5 transcription factor |
| chr15_+_58430567 | 3.42 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
| chr6_-_108145499 | 3.34 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
| chr4_-_41884582 | 3.33 |
ENST00000499082.2
|
LINC00682
|
long intergenic non-protein coding RNA 682 |
| chr11_-_15643937 | 3.33 |
ENST00000533082.1
|
RP11-531H8.2
|
RP11-531H8.2 |
| chr3_-_57233966 | 3.33 |
ENST00000473921.1
ENST00000295934.3 |
HESX1
|
HESX homeobox 1 |
| chr3_+_137490748 | 3.23 |
ENST00000478772.1
|
RP11-2A4.3
|
RP11-2A4.3 |
| chr12_-_12674032 | 3.19 |
ENST00000298573.4
|
DUSP16
|
dual specificity phosphatase 16 |
| chr4_-_72649763 | 3.13 |
ENST00000513476.1
|
GC
|
group-specific component (vitamin D binding protein) |
| chr2_-_176948641 | 3.02 |
ENST00000308618.4
|
EVX2
|
even-skipped homeobox 2 |
| chr11_+_128562372 | 2.98 |
ENST00000344954.6
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr11_+_128563652 | 2.76 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr3_-_27764190 | 2.68 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
| chr15_-_70390191 | 2.67 |
ENST00000559191.1
|
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr1_+_186265399 | 2.65 |
ENST00000367486.3
ENST00000367484.3 ENST00000533951.1 ENST00000367482.4 ENST00000367483.4 ENST00000367485.4 ENST00000445192.2 |
PRG4
|
proteoglycan 4 |
| chr6_-_32157947 | 2.64 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr6_-_66417107 | 2.62 |
ENST00000370621.3
ENST00000370618.3 ENST00000503581.1 ENST00000393380.2 |
EYS
|
eyes shut homolog (Drosophila) |
| chr6_+_130339710 | 2.60 |
ENST00000526087.1
ENST00000533560.1 ENST00000361794.2 |
L3MBTL3
|
l(3)mbt-like 3 (Drosophila) |
| chr2_-_145278475 | 2.59 |
ENST00000558170.2
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
| chr14_+_98602380 | 2.56 |
ENST00000557072.1
|
RP11-61O1.2
|
RP11-61O1.2 |
| chr11_-_116371347 | 2.51 |
ENST00000452629.1
|
AP001891.1
|
AP001891.1 |
| chr9_+_135457530 | 2.41 |
ENST00000263610.2
|
BARHL1
|
BarH-like homeobox 1 |
| chr9_+_2159850 | 2.37 |
ENST00000416751.1
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr1_+_168250194 | 2.35 |
ENST00000367821.3
|
TBX19
|
T-box 19 |
| chr6_-_10115007 | 2.23 |
ENST00000485268.1
|
OFCC1
|
orofacial cleft 1 candidate 1 |
| chr14_-_69261310 | 2.22 |
ENST00000336440.3
|
ZFP36L1
|
ZFP36 ring finger protein-like 1 |
| chr6_-_10412600 | 2.19 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr12_-_89746173 | 2.16 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
| chr4_+_129730779 | 2.16 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
| chr14_+_22970526 | 2.13 |
ENST00000390498.1
|
TRAJ39
|
T cell receptor alpha joining 39 |
| chr7_-_27179814 | 2.13 |
ENST00000522788.1
ENST00000521779.1 |
HOXA3
|
homeobox A3 |
| chr4_+_160188889 | 2.11 |
ENST00000264431.4
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
| chr12_-_89746264 | 2.11 |
ENST00000548755.1
|
DUSP6
|
dual specificity phosphatase 6 |
| chr14_+_22977587 | 2.07 |
ENST00000390504.1
|
TRAJ33
|
T cell receptor alpha joining 33 |
| chr6_+_105404899 | 2.04 |
ENST00000345080.4
|
LIN28B
|
lin-28 homolog B (C. elegans) |
| chr20_-_21086975 | 2.04 |
ENST00000420705.1
ENST00000593272.1 |
LINC00237
|
long intergenic non-protein coding RNA 237 |
| chr10_+_118083919 | 2.04 |
ENST00000333254.3
|
CCDC172
|
coiled-coil domain containing 172 |
| chr18_+_28956740 | 2.03 |
ENST00000308128.4
ENST00000359747.4 |
DSG4
|
desmoglein 4 |
| chr6_+_45296048 | 2.01 |
ENST00000465038.2
ENST00000352853.5 ENST00000541979.1 ENST00000371438.1 |
RUNX2
|
runt-related transcription factor 2 |
| chr15_-_98836406 | 1.96 |
ENST00000560360.1
|
CTD-2544M6.1
|
CTD-2544M6.1 |
| chr20_+_5987890 | 1.96 |
ENST00000378868.4
|
CRLS1
|
cardiolipin synthase 1 |
| chr18_-_53019208 | 1.96 |
ENST00000562607.1
|
TCF4
|
transcription factor 4 |
| chr17_-_38956205 | 1.93 |
ENST00000306658.7
|
KRT28
|
keratin 28 |
| chr7_-_84122033 | 1.92 |
ENST00000424555.1
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
| chr17_-_56082455 | 1.90 |
ENST00000578794.1
|
RP11-159D12.5
|
Uncharacterized protein |
| chr12_-_102591604 | 1.89 |
ENST00000329406.4
|
PMCH
|
pro-melanin-concentrating hormone |
| chr4_-_116034979 | 1.88 |
ENST00000264363.2
|
NDST4
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
| chr15_-_54025300 | 1.83 |
ENST00000559418.1
|
WDR72
|
WD repeat domain 72 |
| chr6_+_100054606 | 1.83 |
ENST00000369215.4
|
PRDM13
|
PR domain containing 13 |
| chr12_-_5352315 | 1.81 |
ENST00000536518.1
|
RP11-319E16.1
|
RP11-319E16.1 |
| chr3_-_157824292 | 1.79 |
ENST00000483851.2
|
SHOX2
|
short stature homeobox 2 |
| chr7_-_5463175 | 1.79 |
ENST00000399537.4
ENST00000430969.1 |
TNRC18
|
trinucleotide repeat containing 18 |
| chr10_-_106240032 | 1.76 |
ENST00000447860.1
|
RP11-127O4.3
|
RP11-127O4.3 |
| chr12_-_102874102 | 1.76 |
ENST00000392905.2
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
| chr7_-_115670792 | 1.73 |
ENST00000265440.7
ENST00000393485.1 |
TFEC
|
transcription factor EC |
| chr14_+_97925151 | 1.73 |
ENST00000554862.1
ENST00000554260.1 ENST00000499910.2 |
CTD-2506J14.1
|
CTD-2506J14.1 |
| chrX_+_9431324 | 1.71 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
| chr20_+_52105495 | 1.69 |
ENST00000439873.2
|
AL354993.1
|
Cell growth-inhibiting protein 7; HCG1784586; Uncharacterized protein |
| chr14_-_83262540 | 1.68 |
ENST00000554451.1
|
RP11-11K13.1
|
RP11-11K13.1 |
| chr9_-_123812542 | 1.68 |
ENST00000223642.1
|
C5
|
complement component 5 |
| chr6_+_15401075 | 1.65 |
ENST00000541660.1
|
JARID2
|
jumonji, AT rich interactive domain 2 |
| chr4_+_129730839 | 1.63 |
ENST00000511647.1
|
PHF17
|
jade family PHD finger 1 |
| chr17_-_46657473 | 1.61 |
ENST00000332503.5
|
HOXB4
|
homeobox B4 |
| chr10_+_77056134 | 1.60 |
ENST00000528121.1
ENST00000416398.1 |
ZNF503-AS1
|
ZNF503 antisense RNA 1 |
| chr2_+_176987088 | 1.57 |
ENST00000249499.6
|
HOXD9
|
homeobox D9 |
| chr2_-_163695128 | 1.55 |
ENST00000332142.5
|
KCNH7
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
| chr17_-_38859996 | 1.53 |
ENST00000264651.2
|
KRT24
|
keratin 24 |
| chr17_-_46688334 | 1.52 |
ENST00000239165.7
|
HOXB7
|
homeobox B7 |
| chr3_-_71294304 | 1.52 |
ENST00000498215.1
|
FOXP1
|
forkhead box P1 |
| chr12_-_53994805 | 1.51 |
ENST00000328463.7
|
ATF7
|
activating transcription factor 7 |
| chr14_+_72052983 | 1.51 |
ENST00000358550.2
|
SIPA1L1
|
signal-induced proliferation-associated 1 like 1 |
| chr13_-_46425865 | 1.51 |
ENST00000400405.2
|
SIAH3
|
siah E3 ubiquitin protein ligase family member 3 |
| chr11_-_117695449 | 1.50 |
ENST00000292079.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr2_-_105030466 | 1.49 |
ENST00000449772.1
|
AC068535.3
|
AC068535.3 |
| chr20_-_50418972 | 1.48 |
ENST00000395997.3
|
SALL4
|
spalt-like transcription factor 4 |
| chr16_-_67517716 | 1.47 |
ENST00000290953.2
|
AGRP
|
agouti related protein homolog (mouse) |
| chr2_+_78143006 | 1.46 |
ENST00000443419.1
|
AC073628.1
|
AC073628.1 |
| chr7_-_115670804 | 1.45 |
ENST00000320239.7
|
TFEC
|
transcription factor EC |
| chr3_+_141106643 | 1.44 |
ENST00000514251.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr8_+_92261516 | 1.44 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
| chr6_-_22297730 | 1.42 |
ENST00000306482.1
|
PRL
|
prolactin |
| chr7_-_29235063 | 1.39 |
ENST00000437527.1
ENST00000455544.1 |
CPVL
|
carboxypeptidase, vitellogenic-like |
| chr6_-_154568551 | 1.36 |
ENST00000519190.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
| chr12_-_14133053 | 1.35 |
ENST00000609686.1
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
| chr13_-_95131923 | 1.33 |
ENST00000377028.5
ENST00000446125.1 |
DCT
|
dopachrome tautomerase |
| chr14_-_24551137 | 1.31 |
ENST00000396995.1
|
NRL
|
neural retina leucine zipper |
| chr20_-_50419055 | 1.30 |
ENST00000217086.4
|
SALL4
|
spalt-like transcription factor 4 |
| chr17_+_42634844 | 1.29 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr8_+_78311303 | 1.27 |
ENST00000518706.2
|
RP11-38H17.1
|
RP11-38H17.1 |
| chr12_-_94673956 | 1.26 |
ENST00000551941.1
|
RP11-1105G2.3
|
Uncharacterized protein |
| chr17_-_10452929 | 1.25 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr20_+_59654146 | 1.25 |
ENST00000441660.1
|
RP5-827L5.1
|
RP5-827L5.1 |
| chr12_-_91398796 | 1.21 |
ENST00000261172.3
ENST00000551767.1 |
EPYC
|
epiphycan |
| chr9_-_16253112 | 1.21 |
ENST00000380683.1
|
C9orf92
|
chromosome 9 open reading frame 92 |
| chr10_+_115312825 | 1.20 |
ENST00000537906.1
ENST00000541666.1 |
HABP2
|
hyaluronan binding protein 2 |
| chr14_-_24551195 | 1.20 |
ENST00000560550.1
|
NRL
|
neural retina leucine zipper |
| chr3_-_72149448 | 1.20 |
ENST00000498432.1
|
LINC00877
|
long intergenic non-protein coding RNA 877 |
| chr12_-_109797249 | 1.19 |
ENST00000538041.1
|
RP11-256L11.1
|
RP11-256L11.1 |
| chr5_+_91378410 | 1.19 |
ENST00000507217.1
|
RP11-348J24.2
|
RP11-348J24.2 |
| chr3_-_72149553 | 1.19 |
ENST00000468646.2
ENST00000464271.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
| chr12_-_102874330 | 1.19 |
ENST00000307046.8
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
| chr15_+_80364901 | 1.19 |
ENST00000560228.1
ENST00000559835.1 ENST00000559775.1 ENST00000558688.1 ENST00000560392.1 ENST00000560976.1 ENST00000558272.1 ENST00000558390.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
| chr1_+_244214577 | 1.18 |
ENST00000358704.4
|
ZBTB18
|
zinc finger and BTB domain containing 18 |
| chr4_-_41749724 | 1.18 |
ENST00000510424.1
|
PHOX2B
|
paired-like homeobox 2b |
| chr20_-_21082105 | 1.17 |
ENST00000455890.2
|
LINC00237
|
long intergenic non-protein coding RNA 237 |
| chr7_-_41742697 | 1.16 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
| chr3_+_152017181 | 1.09 |
ENST00000498502.1
ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chr16_-_51185149 | 1.09 |
ENST00000566102.1
ENST00000541611.1 |
SALL1
|
spalt-like transcription factor 1 |
| chr8_-_42234745 | 1.09 |
ENST00000220812.2
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4 |
| chr15_+_96904487 | 1.07 |
ENST00000600790.1
|
AC087477.1
|
Uncharacterized protein |
| chr17_-_46692287 | 1.07 |
ENST00000239144.4
|
HOXB8
|
homeobox B8 |
| chr20_-_50418947 | 1.05 |
ENST00000371539.3
|
SALL4
|
spalt-like transcription factor 4 |
| chr12_-_16430619 | 1.04 |
ENST00000344941.3
|
SLC15A5
|
solute carrier family 15, member 5 |
| chr6_-_154568815 | 1.04 |
ENST00000519344.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
| chr9_+_2717502 | 1.02 |
ENST00000382082.3
|
KCNV2
|
potassium channel, subfamily V, member 2 |
| chr2_+_171034646 | 1.02 |
ENST00000409044.3
ENST00000408978.4 |
MYO3B
|
myosin IIIB |
| chrX_+_123097014 | 1.02 |
ENST00000394478.1
|
STAG2
|
stromal antigen 2 |
| chr2_+_17997763 | 1.01 |
ENST00000281047.3
|
MSGN1
|
mesogenin 1 |
| chr6_-_10415470 | 1.00 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr14_-_89960395 | 0.99 |
ENST00000555034.1
ENST00000553904.1 |
FOXN3
|
forkhead box N3 |
| chr8_-_95449155 | 0.99 |
ENST00000481490.2
|
FSBP
|
fibrinogen silencer binding protein |
| chr12_-_24103841 | 0.97 |
ENST00000541847.1
|
SOX5
|
SRY (sex determining region Y)-box 5 |
| chr17_-_46682321 | 0.97 |
ENST00000225648.3
ENST00000484302.2 |
HOXB6
|
homeobox B6 |
| chr16_-_51185172 | 0.95 |
ENST00000251020.4
|
SALL1
|
spalt-like transcription factor 1 |
| chr17_-_77924627 | 0.95 |
ENST00000572862.1
ENST00000573782.1 ENST00000574427.1 ENST00000570373.1 ENST00000340848.7 ENST00000576768.1 |
TBC1D16
|
TBC1 domain family, member 16 |
| chr7_-_5465045 | 0.95 |
ENST00000399434.2
|
TNRC18
|
trinucleotide repeat containing 18 |
| chr12_-_13248732 | 0.95 |
ENST00000396302.3
|
GSG1
|
germ cell associated 1 |
| chr10_+_77056181 | 0.95 |
ENST00000526759.1
ENST00000533822.1 |
ZNF503-AS1
|
ZNF503 antisense RNA 1 |
| chr8_+_9953214 | 0.94 |
ENST00000382490.5
|
MSRA
|
methionine sulfoxide reductase A |
| chr5_+_173930710 | 0.94 |
ENST00000511707.1
|
RP11-267A15.1
|
RP11-267A15.1 |
| chr17_-_46608272 | 0.93 |
ENST00000577092.1
ENST00000239174.6 |
HOXB1
|
homeobox B1 |
| chr2_-_145277569 | 0.91 |
ENST00000303660.4
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
| chr17_-_10421853 | 0.91 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
| chr7_+_39017504 | 0.90 |
ENST00000403058.1
|
POU6F2
|
POU class 6 homeobox 2 |
| chr2_-_177684007 | 0.90 |
ENST00000451851.1
|
AC092162.1
|
AC092162.1 |
| chr6_-_9939552 | 0.90 |
ENST00000460363.2
|
OFCC1
|
orofacial cleft 1 candidate 1 |
| chr10_-_102989551 | 0.88 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
| chr1_-_216596738 | 0.88 |
ENST00000307340.3
ENST00000366943.2 ENST00000366942.3 |
USH2A
|
Usher syndrome 2A (autosomal recessive, mild) |
| chr12_-_13248562 | 0.87 |
ENST00000457134.2
ENST00000537302.1 |
GSG1
|
germ cell associated 1 |
| chr4_-_36245561 | 0.87 |
ENST00000506189.1
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
| chr2_+_104490735 | 0.87 |
ENST00000537492.1
ENST00000544869.1 |
RP11-76I14.1
|
RP11-76I14.1 |
| chr6_-_136847099 | 0.86 |
ENST00000438100.2
|
MAP7
|
microtubule-associated protein 7 |
| chr4_-_123377880 | 0.86 |
ENST00000226730.4
|
IL2
|
interleukin 2 |
| chr1_+_206557366 | 0.85 |
ENST00000414007.1
ENST00000419187.2 |
SRGAP2
|
SLIT-ROBO Rho GTPase activating protein 2 |
| chr9_+_2015335 | 0.85 |
ENST00000349721.2
ENST00000357248.2 ENST00000450198.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr4_+_129730947 | 0.83 |
ENST00000452328.2
ENST00000504089.1 |
PHF17
|
jade family PHD finger 1 |
| chr12_-_13248705 | 0.82 |
ENST00000396310.2
|
GSG1
|
germ cell associated 1 |
| chr8_-_93107660 | 0.81 |
ENST00000518954.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr10_+_126630692 | 0.80 |
ENST00000359653.4
|
ZRANB1
|
zinc finger, RAN-binding domain containing 1 |
| chr3_+_152017360 | 0.80 |
ENST00000485910.1
ENST00000463374.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chr8_+_9953061 | 0.79 |
ENST00000522907.1
ENST00000528246.1 |
MSRA
|
methionine sulfoxide reductase A |
| chr6_+_144980954 | 0.79 |
ENST00000367525.3
|
UTRN
|
utrophin |
| chr17_-_38911580 | 0.79 |
ENST00000312150.4
|
KRT25
|
keratin 25 |
| chr14_+_22992573 | 0.78 |
ENST00000390516.1
|
TRAJ21
|
T cell receptor alpha joining 21 |
| chr3_-_54962100 | 0.78 |
ENST00000273286.5
|
LRTM1
|
leucine-rich repeats and transmembrane domains 1 |
| chr8_-_93107638 | 0.78 |
ENST00000518823.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr1_+_192286122 | 0.77 |
ENST00000417209.2
|
RGS21
|
regulator of G-protein signaling 21 |
| chr17_-_46692457 | 0.77 |
ENST00000468443.1
|
HOXB8
|
homeobox B8 |
| chr4_-_184243561 | 0.77 |
ENST00000514470.1
ENST00000541814.1 |
CLDN24
|
claudin 24 |
| chr6_-_76782371 | 0.77 |
ENST00000369950.3
ENST00000369963.3 |
IMPG1
|
interphotoreceptor matrix proteoglycan 1 |
| chr5_-_130868688 | 0.76 |
ENST00000504575.1
ENST00000513227.1 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
| chr7_+_18535346 | 0.76 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
| chr15_+_69854027 | 0.76 |
ENST00000498938.2
|
RP11-279F6.1
|
RP11-279F6.1 |
| chr7_+_66800928 | 0.76 |
ENST00000430244.1
|
RP11-166O4.5
|
RP11-166O4.5 |
| chr3_-_69402828 | 0.75 |
ENST00000460709.1
|
FRMD4B
|
FERM domain containing 4B |
| chr16_-_18066399 | 0.75 |
ENST00000569048.1
|
CTA-481E9.4
|
CTA-481E9.4 |
| chr11_-_20181870 | 0.74 |
ENST00000227256.3
ENST00000524983.2 |
DBX1
|
developing brain homeobox 1 |
| chr11_+_115498761 | 0.73 |
ENST00000424313.2
|
AP000997.1
|
AP000997.1 |
| chr4_-_40516560 | 0.72 |
ENST00000513473.1
|
RBM47
|
RNA binding motif protein 47 |
| chr8_+_42873548 | 0.71 |
ENST00000533338.1
ENST00000534420.1 |
HOOK3
RP11-598P20.5
|
hook microtubule-tethering protein 3 Uncharacterized protein |
| chr16_-_73178346 | 0.70 |
ENST00000358463.2
|
C16orf47
|
chromosome 16 open reading frame 47 |
| chr7_+_133261209 | 0.70 |
ENST00000545148.1
|
EXOC4
|
exocyst complex component 4 |
| chr6_+_143929307 | 0.70 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
| chr2_+_66918558 | 0.68 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of HOXA6
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.5 | GO:0035284 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 2.0 | 6.1 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 1.2 | 7.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.2 | 3.5 | GO:0060435 | bronchiole development(GO:0060435) |
| 1.1 | 3.4 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 1.1 | 9.8 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 1.0 | 3.9 | GO:0035905 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.9 | 3.8 | GO:0007403 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.9 | 0.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.9 | 2.7 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.9 | 5.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.9 | 4.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.8 | 4.1 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.8 | 3.2 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.8 | 3.9 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.6 | 2.5 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.5 | 8.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.5 | 1.4 | GO:0021934 | medulla oblongata development(GO:0021550) hindbrain tangential cell migration(GO:0021934) lateral line system development(GO:0048925) |
| 0.4 | 2.2 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.4 | 1.2 | GO:0060279 | negative regulation of B cell differentiation(GO:0045578) positive regulation of ovulation(GO:0060279) |
| 0.3 | 2.0 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 4.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.3 | 5.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.3 | 1.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.3 | 2.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.3 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 | 2.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 3.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.2 | 2.0 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.2 | 0.6 | GO:0097187 | dentinogenesis(GO:0097187) regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 | 0.9 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.2 | 3.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.2 | 2.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 1.6 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.2 | 0.8 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.2 | 0.9 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.2 | 0.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 2.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.2 | 1.4 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 1.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 1.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 4.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 1.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.1 | 0.5 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
| 0.1 | 1.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 1.7 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 2.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 | 3.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.1 | 1.3 | GO:0060022 | hard palate development(GO:0060022) |
| 0.1 | 2.4 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 7.4 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 1.6 | GO:0007379 | segment specification(GO:0007379) |
| 0.1 | 0.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 0.7 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.1 | 3.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 1.9 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.5 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.1 | 4.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.9 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 2.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.8 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 1.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 | 0.7 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 1.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 1.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.7 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 11.3 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 1.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 | 1.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 1.1 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.5 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.0 | 1.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 0.4 | GO:1900165 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 | 6.0 | GO:0030901 | midbrain development(GO:0030901) |
| 0.0 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.0 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 | 4.2 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.2 | GO:0060459 | subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) |
| 0.0 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 | 1.8 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.0 | 1.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 1.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.0 | 1.2 | GO:0007519 | skeletal muscle tissue development(GO:0007519) skeletal muscle organ development(GO:0060538) |
| 0.0 | 0.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.0 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 2.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 1.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.4 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.0 | 3.3 | GO:0007286 | spermatid development(GO:0007286) |
| 0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 | 2.7 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
| 0.0 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 2.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 0.0 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.0 | 0.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 2.0 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
| 0.0 | 1.5 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 1.7 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.0 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 4.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.5 | 3.8 | GO:0070369 | Scrib-APC-beta-catenin complex(GO:0034750) beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.4 | 1.2 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.3 | 0.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.1 | 3.3 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 4.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 2.0 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 0.4 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 5.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 2.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 1.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 9.2 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 1.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 3.8 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.0 | 20.3 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 8.6 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.0 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 1.4 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 9.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 1.7 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 3.6 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 2.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 7.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.0 | 3.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.7 | 2.0 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.5 | 1.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.5 | 1.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.4 | 7.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.3 | 1.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.3 | 2.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.2 | 1.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.2 | 1.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.2 | 11.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 3.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 3.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 2.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 2.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) glycosphingolipid binding(GO:0043208) |
| 0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 1.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 6.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 4.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 2.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 4.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 8.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 2.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 1.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 3.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 5.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 4.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 5.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 1.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 2.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 0.2 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
| 0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 2.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.0 | 1.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.0 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 2.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 1.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 1.7 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.0 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 2.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 2.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 5.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
| 0.0 | 0.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.0 | 2.5 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
| 0.0 | 25.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.0 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 2.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 1.9 | GO:0003774 | motor activity(GO:0003774) |
| 0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 3.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 2.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 7.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 4.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 4.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 3.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 3.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 6.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 2.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 3.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 5.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 1.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 2.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 7.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 4.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 3.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.2 | 3.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 4.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 10.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 3.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 1.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.0 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 3.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 1.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.0 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 1.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 1.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 4.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |